Fanconi anemia history and symptoms: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
No edit summary
Line 2: Line 2:
{{Fanconi anemia}}
{{Fanconi anemia}}


== Overview[edit | edit source] ==
== Overview ==
The majority of patients with [disease name] are asymptomatic
The majority of patients with [disease name] are asymptomatic


Line 9: Line 9:
The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].
The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].


== History and Symptoms[edit | edit source] ==
== History and Symptoms ==
* '''CLINICAL FEATURES'''  
* '''CLINICAL FEATURES'''  
* '''Congenital anomalies''' — Congenital malformations are the most often presenting features of FA. Malformations are reported in 60 to 75 percent of patients, but many in the field believe this represents an underestimate, as many patients with FA do not manifest classical physical findings [68].   
* '''Congenital anomalies''' — Congenital malformations are the most often presenting features of FA. Malformations are reported in 60 to 75 percent of patients, but many in the field believe this represents an underestimate, as many patients with FA do not manifest classical physical findings  <ref name="pmid29757215">{{cite journal| author=Fu X, Liang C, Li F, Wang L, Wu X, Lu A et al.| title=The Rules and Functions of Nucleocytoplasmic Shuttling Proteins. | journal=Int J Mol Sci | year= 2018 | volume= 19 | issue= 5 | pages=  | pmid=29757215 | doi=10.3390/ijms19051445 | pmc=5983729 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29757215  }}</ref>  
* Young adults with more subtle clinical findings increasingly may be identified from genomic sequencing. Despite the high frequency of malformations, only a small percentage of patients with FA (<5 percent) are diagnosed within the first year of life based on classic congenital anomalies. Thus, while the presence of these findings provides an important clue to the diagnosis, their absence does not eliminate the possibility of FA. In a series of 370 patients enrolled in the International FA Registry and a review of over 2000 patients reported in the literature from 1927 to 2009, the most common developmental abnormalities included the following [20,68]: 
* Young adults with more subtle clinical findings increasingly may be identified from genomic sequencing. Despite the high frequency of malformations, only a small percentage of patients with FA (<5 percent) are diagnosed within the first year of life based on classic congenital anomalies. Thus, while the presence of these findings provides an important clue to the diagnosis, their absence does not eliminate the possibility of FA. In a series of 370 patients enrolled in the International FA Registry and a review of over 2000 patients reported in the literature from 1927 to 2009, the most common developmental abnormalities included the following  
* Skin findings (approximately 40 to 60 percent), including hyper- or hypopigmentation or café-au-lait spots   
* Skin findings (approximately 40 to 60 percent), including hyper- or hypopigmentation or café-au-lait spots   
* Short stature (40 to 60 percent)  
* Short stature (40 to 60 percent)  

Revision as of 17:57, 20 June 2018

Fanconi anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fanconi anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fanconi anemia history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fanconi anemia history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fanconi anemia history and symptoms

CDC on Fanconi anemia history and symptoms

Fanconi anemia history and symptoms in the news

Blogs on Fanconi anemia history and symptoms

Directions to Hospitals Treating Fanconi anemia

Risk calculators and risk factors for Fanconi anemia history and symptoms

Overview

The majority of patients with [disease name] are asymptomatic

OR

The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].

History and Symptoms

  • CLINICAL FEATURES
  • Congenital anomalies — Congenital malformations are the most often presenting features of FA. Malformations are reported in 60 to 75 percent of patients, but many in the field believe this represents an underestimate, as many patients with FA do not manifest classical physical findings  [1]
  • Young adults with more subtle clinical findings increasingly may be identified from genomic sequencing. Despite the high frequency of malformations, only a small percentage of patients with FA (<5 percent) are diagnosed within the first year of life based on classic congenital anomalies. Thus, while the presence of these findings provides an important clue to the diagnosis, their absence does not eliminate the possibility of FA. In a series of 370 patients enrolled in the International FA Registry and a review of over 2000 patients reported in the literature from 1927 to 2009, the most common developmental abnormalities included the following
  • Skin findings (approximately 40 to 60 percent), including hyper- or hypopigmentation or café-au-lait spots
  • Short stature (40 to 60 percent)
  • Thumb or other radial ray abnormalities (50 percent)
  • Thumbs absent or hypoplastic, bifid/duplicated, rudimentary, triphalangeal (35 percent)
  • Radii absent or hypoplastic (7 percent)
  • Hands/other such as flat thenar eminence, clinodactyly, polydactyly, missing first metacarpal, dysplastic ulnae (6 percent)
  • Axial skeletal abnormalities (25 percent), especially microcephaly, triangular facies, short/webbed neck, vertebral anomalies
  • Eye malformations (20 to 40 percent), including strabismus and hypo/hypertelorism
  • Renal and urinary tract malformations (approximately 20 to 30 percent) including horseshoe, ectopic, dysplastic, or absent kidney; hydronephrosis; hydroureter
  • Gonadal/Genital malformations • In males, hypospadias, micropenis, undescended/absent testes, infertility (25 percent) • In females, uterus malformation, small ovaries, hypogenitalia (<5 percent)
  • Ear abnormalities (10 to 20 percent) with conductive hearing loss due to middle ear anomalies or atretic ear canal
  • Congenital heart disease (approximately 5 percent) such as patent ductus arteriosus, ventricular septal defect, aortic coarctation, truncus arteriosus
  • Gastrointestinal anomalies (approximately 5 percent) such as tracheoesophageal fistula, esophageal atresia, intestinal atresia, imperforate anus
  • Central nervous system abnormalities (<5 percent) involving the pituitary gland (eg, small, interrupted pituitary stalk syndrome), hydrocephalus, cerebellar hypoplasia, or absent corpus callosum.

History[edit | edit source]

Patients with [disease name]] may have a positive history of:

  • [History finding 1]
  • [History finding 2]
  • [History finding 3]

Common Symptoms[edit | edit source]

Common symptoms of [disease] include:

  • [Symptom 1]
  • [Symptom 2]
  • [Symptom 3]

Less Common Symptoms[edit | edit source]

Less common symptoms of [disease name] include

  • [Symptom 1]
  • [Symptom 2]
  • [Symptom 3]

References

  1. Fu X, Liang C, Li F, Wang L, Wu X, Lu A; et al. (2018). "The Rules and Functions of Nucleocytoplasmic Shuttling Proteins". Int J Mol Sci. 19 (5). doi:10.3390/ijms19051445. PMC 5983729. PMID 29757215.